Bravylol

Description

Bravylol contains nebivolol, a selective β1-blocker, which reduces heart rate, blood pressure and peripheral systemic vascular resistance.

Indications

Bravylol is indicated for the treatment of:
– essential hypertension;
– stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients (>70 years).

Subject to medical prescription.

Concentration and pharmaceutical form: 5 mg tablets

Patient information leaflet